30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Old API Wind-Down Ltd (ARLZQ)

Track

Stock chart
Ticker: ARLZQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
KOVEN ANDREW I
President & Chief Business Off
1 sale — total 58,590 USD
Planned sale 4 Jun 2018
Value US$298,073.75 | Price 378.28 | Shares 2,958
Planned sale 14 May 2018
Value US$1,560,359.13 | Price 94.07 | Shares 64,032
Planned sale 14 May 2018
Value US$7,261.28 | Price 0.52 | Shares 13,964
Planned sale 19 Mar 2018
Value US$9,732.50 | Price 1.70 | Shares 5,725
Planned sale 19 Mar 2018
Value US$5,900.70 | Price 1.70 | Shares 3,471
Planned sale 19 Mar 2018
Value US$16,556.30 | Price 1.70 | Shares 9,739
Planned sale 19 Mar 2018
Value US$10,115.00 | Price 1.70 | Shares 5,950
Buy 8 Dec 2017
Value US$73,535.00 | Price 1.47 | Shares 50,000
Planned sale 2 Oct 2017
Value US$24,917.93 | Price 2.50 | Shares 9,960
Planned sale 28 Jul 2017
Value US$13,509.32 | Price 1.25 | Shares 10,804
Planned sale 23 Jun 2017
Value US$10,267.60 | Price 1.33 | Shares 7,720
Buy 15 Jun 2017
Value US$17,181.00 | Price 1.15 | Shares 15,000
Buy 14 Jun 2017
Value US$58,525.00 | Price 1.17 | Shares 50,000
Sale 5 Jun 2017
Value US$207,110.16 | Price 1.28 | Shares 161,906
Sale 23 May 2017
Value US$146,877.74 | Price 1.41 | Shares 104,176
Sale 22 May 2017
Value US$332,365.04 | Price 1.42 | Shares 233,468
Sale 19 May 2017
Value US$79,557.61 | Price 1.56 | Shares 51,041
Planned sale 20 Mar 2017
Value US$12,544.05 | Price 2.41 | Shares 5,205
Planned sale 20 Mar 2017
Value US$18,858.25 | Price 2.41 | Shares 7,825
Buy 15 Mar 2017
Value US$102,249.00 | Price 2.27 | Shares 45,000
Buy 15 Mar 2017
Value US$50,920.00 | Price 2.55 | Shares 20,000
Buy 15 Mar 2017
Value US$10,022.50 | Price 2.11 | Shares 4,750
Buy 15 Mar 2017
Value US$1,230,950.00 | Price 2.46 | Shares 500,000
Buy 15 Mar 2017
Value US$33,949.50 | Price 2.26 | Shares 15,000
Buy 15 Mar 2017
Value US$12,618.50 | Price 2.52 | Shares 5,000
Planned sale 29 Nov 2016
Value US$523,146.08 | Price 4.99 | Shares 104,778
Planned sale 28 Nov 2016
Value US$93,000.00 | Price 4.65 | Shares 20,000
Buy 14 Nov 2016
Value US$4,950.00 | Price 4.95 | Shares 1,000
Buy 11 Nov 2016
Value US$143,121.00 | Price 4.77 | Shares 30,000
Buy 16 Sep 2016
Value US$1,732,664.30 | Price 5.86 | Shares 295,929
Planned sale 15 Sep 2016
Value US$453,217.50 | Price 6.04 | Shares 75,000
Planned sale 15 Sep 2016
Value US$420,000.00 | Price 5.60 | Shares 75,000
Buy 20 May 2016
Value US$37,500.00 | Price 3.75 | Shares 10,000
Buy 16 May 2016
Value US$92,050.00 | Price 3.68 | Shares 25,000
Buy 16 May 2016
Value US$37,570.00 | Price 3.76 | Shares 10,000
Buy 16 May 2016
Value US$17,037.45 | Price 3.79 | Shares 4,500
Buy 13 May 2016
Value US$3,500.00 | Price 3.50 | Shares 1,000
Buy 12 May 2016
Value US$17,449.50 | Price 3.49 | Shares 5,000
Buy 12 May 2016
Value US$78,547.50 | Price 3.49 | Shares 22,500
Buy 12 May 2016
Value US$174,495.00 | Price 3.49 | Shares 50,000
Buy 12 May 2016
Value US$249,470.65 | Price 3.49 | Shares 71,500
Sale 17 Mar 2016
Value US$15,000,000.00 | Price 6.25 | Shares 2,400,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-06-06 2018-06-04 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
2,958 +35.2%
378.28
US$298,074 		2,958 +35.2% 378.28 US$298,074
2018-05-16 2018-05-14 PlS Planned sale Tursi James Patrick

Chief Medical Officer

Officer
64,032 -41.7%
94.07
US$1,560,359 		64,032 -41.7% 94.07 US$1,560,359
2018-05-16 2018-05-14 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off

Officer
45,356 -39.1%
306.01
US$1,126,771 		45,356 -39.1% 306.01 US$1,126,771
2018-03-21 2018-03-19 PlS Planned sale Glickman Mark A

Chief Commercial Officer
5,725 -2.2%
1.70
US$9,732 		5,725 -2.2% 1.70 US$9,732
2018-03-21 2018-03-19 PlS Planned sale Trachtenberg Eric

GC, CCO & Secretary
3,471 -1.7%
1.70
US$5,901 		3,471 -1.7% 1.70 US$5,901
2018-03-21 2018-03-19 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
9,739 -0.7%
1.70
US$16,556 		9,739 -0.7% 1.70 US$16,556
2018-03-21 2018-03-19 PlS Planned sale Tursi James Patrick

Chief Medical Officer
5,950 -2.3%
1.70
US$10,115 		5,950 -2.3% 1.70 US$10,115
2017-12-12 2017-12-08 B Purchase Kirsch Arthur S
50,000 +22.6%
1.47
US$73,535 		50,000 +22.6% 1.47 US$73,535
2017-10-04 2017-10-02 PlS Planned sale Tursi James Patrick

Chief Medical Officer
9,960 -3.7%
2.50
US$24,918 		9,960 -3.7% 2.50 US$24,918
2017-07-28 2017-07-28 PlS Planned sale
Charles Scott J

Chief Financial Officer

Officer
10,804 -3.7%
1.25
US$13,509 		10,804 -3.7% 1.25 US$13,509
2017-06-23 2017-06-23 PlS Planned sale
Trachtenberg Eric

GC, CCO & Secretary
7,720 -3.7%
1.33
US$10,268 		7,720 -3.7% 1.33 US$10,268
2017-06-19 2017-06-15 B Purchase Kirsch Arthur S
15,000 +7.3%
1.15
US$17,181 		15,000 +7.3% 1.15 US$17,181
2017-06-16 2017-06-14 B Purchase Kirsch Arthur S
50,000 +31.9%
1.17
US$58,525 		50,000 +31.9% 1.17 US$58,525
2017-06-06 2017-06-05 S Sale
KOVEN ANDREW I

President & Chief Business Off
161,906 -10.6%
1.28
US$207,110 		161,906 -10.6% 1.28 US$207,110
2017-05-24 2017-05-23 S Sale Aryeh Jason Non-Executive Director
104,176 -100.0%
1.41
US$146,878 		104,176 -100.0% 1.41 US$146,878
2017-05-24 2017-05-22 S Sale Aryeh Jason Non-Executive Director
233,468 -69.1%
1.42
US$332,365 		233,468 -69.1% 1.42 US$332,365
2017-05-24 2017-05-19 S Sale Aryeh Jason Non-Executive Director
51,041 -13.1%
1.56
US$79,558 		51,041 -13.1% 1.56 US$79,558
2017-03-22 2017-03-20 PlS Planned sale
Charles Scott J

Chief Financial Officer
5,205 -2.4%
2.41
US$12,544 		5,205 -2.4% 2.41 US$12,544
2017-03-22 2017-03-20 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
7,825 -0.5%
2.41
US$18,858 		7,825 -0.5% 2.41 US$18,858
2017-03-17 2017-03-15 B Purchase Kirsch Arthur S
45,000 +43.2%
2.27
US$102,249 		45,000 +43.2% 2.27 US$102,249
2017-03-17 2017-03-15 B Purchase KOVEN ANDREW I

President & Chief Business Off
20,000 +1.4%
2.55
US$50,920 		20,000 +1.4% 2.55 US$50,920
2017-03-17 2017-03-15 B Purchase Tursi James Patrick

Chief Medical Officer
4,750 +2.6%
2.11
US$10,022 		4,750 +2.6% 2.11 US$10,022
2017-03-17 2017-03-15 B Purchase ADAMS ADRIAN

Chief Executive Officer

Executive Director
500,000 +16.3%
2.46
US$1,230,950 		500,000 +16.3% 2.46 US$1,230,950
2017-03-17 2017-03-15 B Purchase RUDNICK SETH Non-Executive Director
15,000 +23.3%
2.26
US$33,950 		15,000 +23.3% 2.26 US$33,950
2017-03-17 2017-03-15 B Purchase LEE KENNETH B JR Non-Executive Director
5,000 +5.5%
2.52
US$12,618 		5,000 +5.5% 2.52 US$12,618
2016-11-30 2016-11-29 PlS Planned sale Harris Robert Paul Non-Executive Director
104,778 -15.0%
4.99
US$523,146 		104,778 -15.0% 4.99 US$523,146
2016-11-30 2016-11-28 PlS Planned sale Harris Robert Paul Non-Executive Director
20,000 -3.3%
4.65
US$93,000 		20,000 -3.3% 4.65 US$93,000
2016-11-15 2016-11-14 B Purchase LEE KENNETH B JR Non-Executive Director
1,000 +1.1%
4.95
US$4,950 		1,000 +1.1% 4.95 US$4,950
2016-11-15 2016-11-11 B Purchase RUDNICK SETH Non-Executive Director
30,000 +46.6%
4.77
US$143,121 		30,000 +46.6% 4.77 US$143,121
2017-04-25 2016-09-16 B Purchase Aryeh Jason
295,929 +625.8%
5.86
US$1,732,664 		295,929 +625.8% 5.86 US$1,732,664
2016-09-19 2016-09-15 PlS Planned sale Harris Robert Paul Non-Executive Director
75,000 -11.2%
6.04
US$453,218 		75,000 -11.2% 6.04 US$453,218
2016-09-19 2016-09-15 PlS Planned sale Harris Robert Paul Non-Executive Director
75,000 -10.1%
5.60
US$420,000 		75,000 -10.1% 5.60 US$420,000
2016-05-23 2016-05-20 B Purchase Tursi James Patrick

Chief Medical Officer

Officer
10,000 +5.9%
3.75
US$37,500 		10,000 +5.9% 3.75 US$37,500
2016-05-18 2016-05-16 B Purchase Glickman Mark A

Chief Commercial Officer

Officer
25,000 +15.5%
3.68
US$92,050 		25,000 +15.5% 3.68 US$92,050
2016-05-18 2016-05-16 B Purchase Trachtenberg Eric

GC, CCO & Secretary

Officer
10,000 +7.4%
3.76
US$37,570 		10,000 +7.4% 3.76 US$37,570
2016-05-18 2016-05-16 B Purchase Tursi James Patrick

Chief Medical Officer

Officer
4,500 +2.7%
3.79
US$17,037 		4,500 +2.7% 3.79 US$17,037
2016-05-17 2016-05-13 B Purchase LEE KENNETH B JR Non-Executive Director
1,000 +1.2%
3.50
US$3,500 		1,000 +1.2% 3.50 US$3,500
2016-05-16 2016-05-12 B Purchase Kirsch Arthur S Non-Executive Director
5,000 +inf%
3.49
US$17,450 		5,000 +inf% 3.49 US$17,450
2016-05-16 2016-05-12 B Purchase Kirsch Arthur S Non-Executive Director
22,500 +30.4%
3.49
US$78,548 		22,500 +30.4% 3.49 US$78,548
2016-05-16 2016-05-12 B Purchase Charles Scott J

Chief Financial Officer

Officer
50,000 +30.6%
3.49
US$174,495 		50,000 +30.6% 3.49 US$174,495
2016-05-13 2016-05-12 B Purchase KOVEN ANDREW I

President & Chief Business Off

Officer
71,500 +4.6%
3.49
US$249,471 		71,500 +4.6% 3.49 US$249,471
2016-04-07 2016-03-17 S Sale QLT INC/BC Large shareholder
2,400,000 -33.3%
6.25
US$15,000,000 		2,400,000 -33.3% 6.25 US$15,000,000
Explore more

More insider trading research around Old API Wind-Down Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America